Eagle Materials, Inc. (EXP) Analysts See $1.56 EPS; Shorts at Roka Bioscience (ROKA) Lowered By 20.61%

October 13, 2017 - By Darrin Black

Analysts expect Eagle Materials, Inc. (NYSE:EXP) to report $1.56 EPS on October, 23.They anticipate $0.31 EPS change or 24.80% from last quarter’s $1.25 EPS. EXP’s profit would be $75.76M giving it 17.49 P/E if the $1.56 EPS is correct. After having $1.17 EPS previously, Eagle Materials, Inc.’s analysts see 33.33% EPS growth. The stock increased 1.46% or $1.57 on October 12, reaching $109.13. About shares traded. Eagle Materials, Inc. (NYSE:EXP) has risen 36.20% since October 13, 2016 and is uptrending. It has outperformed by 19.50% the S&P500.

Roka Bioscience Incorporated (NASDAQ:ROKA) had a decrease of 20.61% in short interest. ROKA’s SI was 163,700 shares in October as released by FINRA. Its down 20.61% from 206,200 shares previously. With 137,000 avg volume, 1 days are for Roka Bioscience Incorporated (NASDAQ:ROKA)’s short sellers to cover ROKA’s short positions. The SI to Roka Bioscience Incorporated’s float is 9.54%. The stock increased 21.67% or $0.39 during the last trading session, reaching $2.19. About shares traded. Roka Bioscience Inc (NASDAQ:ROKA) has declined 50.49% since October 13, 2016 and is downtrending. It has underperformed by 67.19% the S&P500.

Eagle Materials Inc. is a supplier of construction products, building materials and materials used for oil and natural gas extraction. The company has market cap of $5.30 billion. The Firm operates through five divisions: Cement, Concrete and Aggregates, Gypsum Wallboard, Recycled Paperboard, and Oil and Gas Proppants. It has a 25.42 P/E ratio. The Company’s construction products are used in residential, industrial, commercial and infrastructure construction, and include cement, slag, concrete and aggregates.

Among 8 analysts covering Eagle Materials (NYSE:EXP), 5 have Buy rating, 0 Sell and 3 Hold. Therefore 63% are positive. Eagle Materials had 23 analyst reports since August 5, 2015 according to SRatingsIntel. The firm has “Hold” rating by Standpoint Research given on Thursday, September 28. On Thursday, August 31 the stock rating was maintained by Stifel Nicolaus with “Buy”. The rating was downgraded by CL King to “Neutral” on Tuesday, July 26. The stock of Eagle Materials, Inc. (NYSE:EXP) has “Strong Buy” rating given on Monday, December 14 by CL King. The company was downgraded on Wednesday, November 9 by Standpoint Research. The company was upgraded on Tuesday, October 4 by CL King. The stock has “Buy” rating by Stifel Nicolaus on Thursday, July 13. The firm has “Buy” rating given on Monday, July 31 by Citigroup. The firm has “Buy” rating given on Monday, March 28 by BB&T Capital. The firm has “Neutral” rating by Citigroup given on Monday, December 5.

Investors sentiment decreased to 1.18 in 2017 Q2. Its down 0.41, from 1.59 in 2017Q1. It fall, as 40 investors sold Eagle Materials, Inc. shares while 91 reduced holdings. 39 funds opened positions while 116 raised stakes. 43.40 million shares or 2.46% less from 44.49 million shares in 2017Q1 were reported. Raymond James Svcs Advisors invested 0% in Eagle Materials, Inc. (NYSE:EXP). Airain holds 2,377 shares or 0.01% of its portfolio. Alps Advisors has 4,957 shares for 0% of their portfolio. Old Mutual Invsts (Uk) owns 2,100 shares. Natixis stated it has 0% of its portfolio in Eagle Materials, Inc. (NYSE:EXP). Teacher Retirement Sys Of Texas holds 0% or 3,930 shares in its portfolio. Ny State Common Retirement Fund holds 156,591 shares or 0.02% of its portfolio. Greenwood Capital Assoc Ltd accumulated 2,456 shares. Friess Assocs Limited Co stated it has 143,200 shares. Morgan Stanley reported 255,495 shares stake. 6,582 were reported by Aqr Capital Mngmt Llc. Coldstream Cap Inc invested in 0.03% or 2,210 shares. Panagora Asset Management reported 2,873 shares. Gsa Partners Llp reported 7,319 shares stake. Rhumbline Advisers invested in 0.02% or 102,818 shares.

Since May 8, 2017, it had 0 buys, and 2 selling transactions for $2.10 million activity. Powers David B also sold $1.09M worth of Eagle Materials, Inc. (NYSE:EXP) on Monday, May 8. Graass James H also sold $1.01 million worth of Eagle Materials, Inc. (NYSE:EXP) on Friday, May 19.

Among 5 analysts covering Roka Bioscience (NASDAQ:ROKA), 2 have Buy rating, 0 Sell and 3 Hold. Therefore 40% are positive. Roka Bioscience had 9 analyst reports since August 14, 2015 according to SRatingsIntel. The firm earned “Hold” rating on Tuesday, August 25 by Zacks. The company was initiated on Tuesday, December 13 by Roth Capital. The firm has “Hold” rating given on Tuesday, September 8 by Zacks. TH Capital initiated the shares of ROKA in report on Tuesday, December 13 with “Buy” rating. The company was maintained on Friday, August 14 by Leerink Swann. Leerink Swann downgraded Roka Bioscience Inc (NASDAQ:ROKA) on Monday, March 7 to “Market Perform” rating.

Roka Bioscience, Inc. is a molecular diagnostics company. The company has market cap of $10.97 million. The Firm is focused on the development and commercialization of molecular assay technologies for the detection of foodborne pathogens under the Atlas brand name. It currently has negative earnings. The Firm offers Atlas Detection Assays and Atlas instrument in the North American food safety testing market and has rights to develop and commercialize its molecular testing solutions for a range of other industrial applications.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:

Twitter Auto Publish Powered By : XYZScripts.com